Pulmonary Fibrosis and Decreased DLCO on PFTs
Yes, pulmonary fibrosis characteristically shows a decreased DLCO on pulmonary function testing, often representing the earliest and most sensitive abnormality detectable. 1
Characteristic PFT Pattern in Pulmonary Fibrosis
Decreased DLCO is a hallmark finding in pulmonary fibrosis and typically appears before other pulmonary function abnormalities become evident. 1, 2
- The European Respiratory Society confirms that DLCO reduction is the earliest and most sensitive PFT abnormality in interstitial lung disease (ILD), frequently preceding changes in lung volumes 2
- Patients with ILD, sarcoidosis, and pulmonary fibrosis usually demonstrate a low DLCO 1
- In idiopathic pulmonary fibrosis (IPF) specifically, mean DLCO at diagnosis is approximately 60% of predicted 3
Severity Grading of DLCO Reduction
The degree of DLCO impairment in pulmonary fibrosis can be categorized as: 1
- Mild: >60% and <lower limit of normal
- Moderate: 40-60% of predicted
- Severe: <40% of predicted
A DLCO <45% of predicted is associated with poor outcomes and increased mortality. 4
Associated PFT Findings
Beyond isolated DLCO reduction, pulmonary fibrosis demonstrates a characteristic restrictive pattern: 5, 3
- Restrictive ventilatory impairment confirmed by reduced total lung capacity (TLC), with proportional reduction of all lung compartments including TLC and residual volume 5
- At initial diagnosis of IPF, 73% of patients have a restrictive pattern with mean TLC of 72% of predicted 3
- Mean forced vital capacity (FVC) is approximately 71% of predicted, though 44% of patients have FVC <95th percentile at diagnosis 3
- Important caveat: One in four patients with IPF have normal TLC and more than half have normal FVC during initial evaluation, making DLCO reduction particularly valuable for early detection 3
Pathophysiologic Basis
The severe DLCO reduction in pulmonary fibrosis reflects: 5, 6
- Loss of normally functioning alveolar-capillary units 6
- Reduced effective surface area available for gas exchange 6
- Thickening of the alveolar-capillary membrane from fibrotic tissue 5
- Destruction of pulmonary capillary bed 5
As restriction severity increases, DLCO progressively decreases (74% of predicted in mild restriction to 39% in severe restriction), while DLCO/VA (DLCO corrected for alveolar volume) paradoxically remains within normal limits regardless of restriction severity 3
Diagnostic Interpretation Algorithm
When encountering decreased DLCO on PFTs: 1, 2
If restriction is present with decreased DLCO: Strongly suggests ILD/pulmonary fibrosis rather than chest wall or neuromuscular disorders (which show normal DLCO) 1
If spirometry and lung volumes are normal with decreased DLCO: Consider early ILD, early emphysema, pulmonary vascular disorders, or anemia 1
Next diagnostic steps for suspected pulmonary fibrosis: 2
Prognostic Significance
DLCO serves as a critical prognostic marker in pulmonary fibrosis: 7, 8
- A threshold of 10% decrease in FVC or 5% decrease with corroborative 15% drop in DLCO predicts survival 7
- Changes in DLCO are highly predictive of long-term outcomes, especially over the next 2 years 7
- Five-year survival is 70.4% in preserved-DLCO group (>40% predicted) versus 20.0% in low-DLCO group (<40% predicted) 8
- The relative risk of mortality within 5 years is 2.70 (95% CI 1.46-4.99) in the low-DLCO group 8
Monitoring Recommendations
Serial PFTs every 3-6 months for at least 1 year are required to establish disease trajectory and determine treatment necessity 2
- DLCO measurements should be adjusted for hemoglobin and carboxyhaemoglobin levels, particularly when monitoring for drug toxicity or in patients undergoing chemotherapy 1
- Exercise testing may provide additional diagnostic value, as DLCO shows better correlation with blood gas abnormalities during exercise than at rest 9